Cargando…

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia

HIGHLIGHTS: What are the main findings? The identification of patients with CAP at high risk for resistant pathogens is of outstanding clinical interest due to the worse outcome of these patients. However, the HCAP classification and the scores proposed in literature to identify resistant pathogens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amati, Francesco, Bindo, Francesco, Stainer, Anna, Gramegna, Andrea, Mantero, Marco, Nigro, Mattia, Bussini, Linda, Bartoletti, Michele, Blasi, Francesco, Aliberti, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295768/ https://www.ncbi.nlm.nih.gov/pubmed/37366804 http://dx.doi.org/10.3390/arm91030018

Ejemplares similares

Cardiovascular Complications in Community-Acquired Pneumonia
por: Desai, Antonio, et al.
Publicado: (2022)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023)

Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy
por: Di Pasquale, Marta, et al.
Publicado: (2017)

Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP
por: Amati, Francesco, et al.
Publicado: (2021)

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2018)

Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
por: Suska, Kseniia, et al.
Publicado: (2022)

Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?
por: Di Pasquale, Marta, et al.
Publicado: (2016)

Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2020)

Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022)

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
por: Amati, Francesco, et al.
Publicado: (2022)

Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023)

Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review
por: Vanoni, Nicolò Maria, et al.
Publicado: (2019)

T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Di Pasquale, Marta Francesca, et al.
Publicado: (2019)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
por: Sotgiu, Giovanni, et al.
Publicado: (2018)

Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study
por: Aliberti, Stefano, et al.
Publicado: (2016)

Mixed community-acquired lower respiratory tract infections
por: Tarsia, Paolo, et al.
Publicado: (2007)

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
por: Blasi, Francesco, et al.
Publicado: (2021)

The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019)

An international perspective on hospitalized patients with viral community-acquired pneumonia
por: Radovanovic, Dejan, et al.
Publicado: (2019)

Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy
por: Mantero, Marco, et al.
Publicado: (2017)

Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
por: Carugati, Manuela, et al.
Publicado: (2018)

Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia
por: Aliberti, Stefano, et al.
Publicado: (2016)

Neutrophil elastase in bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2017)

Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia
por: Aliberti, Stefano, et al.
Publicado: (2015)

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
por: Aliberti, Stefano, et al.
Publicado: (2014)

Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review
por: Gramegna, Andrea, et al.
Publicado: (2022)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

Prevalence and incidence of bronchiectasis in Italy
por: Aliberti, Stefano, et al.
Publicado: (2020)

Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendations
por: Mantero, Marco, et al.
Publicado: (2017)

Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study
por: Santus, Pierachille, et al.
Publicado: (2022)

Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia
por: Fernandez-Botran, Rafael, et al.
Publicado: (2014)

Risk factors for community-acquired pneumonia in adults in Europe: a literature review
por: Torres, Antoni, et al.
Publicado: (2013)

Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients
por: Terranova, Leonardo, et al.
Publicado: (2022)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
por: Gaibani, Paolo, et al.
Publicado: (2022)

Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: do we need a personalized approach?
por: Paolini, Valentina, et al.
Publicado: (2018)

Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study
por: Crimi, Claudia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldmpisijveupcp74urf7olb36d